These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34424523)

  • 1. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats.
    Miura K; Oiwa Y; Kawamura Y
    Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats.
    Miyawaki S; Kawamura Y; Oiwa Y; Shimizu A; Hachiya T; Bono H; Koya I; Okada Y; Kimura T; Tsuchiya Y; Suzuki S; Onishi N; Kuzumaki N; Matsuzaki Y; Narita M; Ikeda E; Okanoya K; Seino K; Saya H; Okano H; Miura K
    Nat Commun; 2016 May; 7():11471. PubMed ID: 27161380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naked mole rats can undergo developmental, oncogene-induced and DNA damage-induced cellular senescence.
    Zhao Y; Tyshkovskiy A; Muñoz-Espín D; Tian X; Serrano M; de Magalhaes JP; Nevo E; Gladyshev VN; Seluanov A; Gorbunova V
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1801-1806. PubMed ID: 29432174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming.
    Tan L; Ke Z; Tombline G; Macoretta N; Hayes K; Tian X; Lv R; Ablaeva J; Gilbert M; Bhanu NV; Yuan ZF; Garcia BA; Shi YG; Shi Y; Seluanov A; Gorbunova V
    Stem Cell Reports; 2017 Nov; 9(5):1721-1734. PubMed ID: 29107597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naked Mole Rat Induced Pluripotent Stem Cells and Their Contribution to Interspecific Chimera.
    Lee SG; Mikhalchenko AE; Yim SH; Lobanov AV; Park JK; Choi KH; Bronson RT; Lee CK; Park TJ; Gladyshev VN
    Stem Cell Reports; 2017 Nov; 9(5):1706-1720. PubMed ID: 29107591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
    Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
    Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
    Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.
    Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA
    Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.
    Utikal J; Polo JM; Stadtfeld M; Maherali N; Kulalert W; Walsh RM; Khalil A; Rheinwald JG; Hochedlinger K
    Nature; 2009 Aug; 460(7259):1145-8. PubMed ID: 19668190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenesis resistance in the longest-lived rodent, the naked mole-rat.
    Yamamura Y; Kawamura Y; Oka K; Miura K
    Cancer Sci; 2022 Dec; 113(12):4030-4036. PubMed ID: 36083242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors.
    Yilmazer A; de Lázaro I; Bussy C; Kostarelos K
    J Vis Exp; 2013 Dec; (82):e50837. PubMed ID: 24378537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo.
    Ohnishi K; Semi K; Yamada Y
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naked mole rat iPSC line expressing drug-inducible mouse pluripotency factors developed from embryonic fibroblasts.
    Lee SG; Mikhalchenko AE; Yim SH; Gladyshev VN
    Stem Cell Res; 2018 Aug; 31():197-200. PubMed ID: 30107334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
    Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
    Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology.
    Laplane L; Beke A; Vainchenker W; Solary E
    Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming and carcinogenesis--parallels and distinctions.
    Wasik AM; Grabarek J; Pantovic A; Cieślar-Pobuda A; Asgari HR; Bundgaard-Nielsen C; Rafat M; Dixon IM; Ghavami S; Łos MJ
    Int Rev Cell Mol Biol; 2014; 308():167-203. PubMed ID: 24411172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.